Kathrin Schwarte

1.1k total citations
25 papers, 639 citations indexed

About

Kathrin Schwarte is a scholar working on Molecular Biology, Biological Psychiatry and Behavioral Neuroscience. According to data from OpenAlex, Kathrin Schwarte has authored 25 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Biological Psychiatry and 8 papers in Behavioral Neuroscience. Recurrent topics in Kathrin Schwarte's work include Stress Responses and Cortisol (8 papers), Epigenetics and DNA Methylation (8 papers) and Tryptophan and brain disorders (8 papers). Kathrin Schwarte is often cited by papers focused on Stress Responses and Cortisol (8 papers), Epigenetics and DNA Methylation (8 papers) and Tryptophan and brain disorders (8 papers). Kathrin Schwarte collaborates with scholars based in Germany, Australia and Japan. Kathrin Schwarte's co-authors include Volker Arolt, Katharina Domschke, Jürgen Deckert, Peter Zwanzger, Nicola Tidow, Bernhard T. Baune, Klaus‐Peter Lesch, Andreas Reif, Oliver Ambrée and Benedikt Klauke and has published in prestigious journals such as Scientific Reports, International Journal of Molecular Sciences and Journal of Neurochemistry.

In The Last Decade

Kathrin Schwarte

24 papers receiving 634 citations

Peers

Kathrin Schwarte

IMMUN

Federica Klaus United States

Blanca Morales Spain

Silke Jörgens Germany

Tzu‐Yun Wang Taiwan

Wolfgang Maier Germany

Emanuela Morelli Italy

Markus H. Skowronek Germany

Hazel Platt United Kingdom

Csilla Szabó Hungary

Yoav Kohn Israel

Federica Klaus United States

Kathrin Schwarte

103 ×0.5

153 ×0.9

43 ×0.3

85 ×0.9

48 ×0.6

IMMUN

Citations per year, relative to Kathrin Schwarte Kathrin Schwarte (= 1×) peers Federica Klaus

Countries citing papers authored by Kathrin Schwarte

Since Specialization

Citations

This map shows the geographic impact of Kathrin Schwarte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Schwarte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Schwarte more than expected).

Fields of papers citing papers by Kathrin Schwarte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathrin Schwarte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Schwarte. The network helps show where Kathrin Schwarte may publish in the future.

Co-authorship network of co-authors of Kathrin Schwarte

This figure shows the co-authorship network connecting the top 25 collaborators of Kathrin Schwarte. A scholar is included among the top collaborators of Kathrin Schwarte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathrin Schwarte. Kathrin Schwarte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mills, Natalie, Hikaru Hori, Micah Cearns, et al.. (2024). Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo. Brain Behavior and Immunity. 123. 43–56. 4 indexed citations

Assche, E. Van, et al.. (2024). Long-Term Immunomodulatory Impact of VNS on Peripheral Cytokine Profiles and Its Relationship with Clinical Response in Difficult-to-Treat Depression (DTD). International Journal of Molecular Sciences. 25(8). 4196–4196. 1 indexed citations

Schiele, Miriam A., Kathrin Schwarte, Pascal Schlosser, et al.. (2024). Epigenome-Wide DNA Methylation in Unipolar Depression: Predictive Biomarker of Antidepressant Treatment Response?. The International Journal of Neuropsychopharmacology. 27(11).

Mills, Natalie, Hikaru Hori, Kathrin Schwarte, et al.. (2023). Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study. The Journal of Clinical Psychiatry. 84(6). 1 indexed citations

Mills, Natalie, Hikaru Hori, Kathrin Schwarte, et al.. (2023). Inflammation‐stratified augmentation of vortioxetine with celecoxib: Results from a double‐blind, randomized, placebo‐controlled trial in major depressive disorder. Journal of Neurochemistry. 168(9). 1817–1825. 7 indexed citations

Beins, Eva C., Kathrin Schwarte, Carlo Maj, et al.. (2022). Chemokine receptor 4 expression on blood T lymphocytes predicts severity of major depressive disorder. Journal of Affective Disorders. 310. 343–353. 3 indexed citations

Schwarte, Kathrin, Judith Bühlmeier, Anke Hinney, et al.. (2022). Expression of CXCR4 on CD4+ T cells predicts body composition parameters in female adolescents with anorexia nervosa. Frontiers in Psychiatry. 13. 960905–960905. 2 indexed citations

Schwarte, Kathrin, et al.. (2022). Immunological changes following electroconvulsive therapy in multiple sclerosis. Journal of Psychiatric Research. 150. 180–183. 1 indexed citations

Schwarte, Kathrin, Judith Bühlmeier, Anke Hinney, et al.. (2021). Alterations in B cell subsets correlate with body composition parameters in female adolescents with anorexia nervosa. Scientific Reports. 11(1). 1125–1125. 8 indexed citations

10.

Hohoff, Christa, Tina Kroll, Kathrin Schwarte, et al.. (2020). ADORA2A variation and adenosine A1 receptor availability in the human brain with a focus on anxiety-related brain regions: modulation by ADORA1 variation. Translational Psychiatry. 10(1). 406–406. 16 indexed citations

11.

Jörgens, Silke, Volker Arolt, Katharina Domschke, et al.. (2020). Association of 5-HTTLPR/rs25531 with depressive symptoms in patients with coronary heart disease: A prospective study. Journal of Affective Disorders. 277. 531–539. 4 indexed citations

12.

Jörgens, Silke, Volker Arolt, Katharina Domschke, et al.. (2020). Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: a prospective study. Journal of Neural Transmission. 127(12). 1651–1662. 6 indexed citations

13.

Schiele, Miriam A., Peter Zwanzger, Kathrin Schwarte, et al.. (2020). Serotonin Transporter Gene Promoter Hypomethylation as a Predictor of Antidepressant Treatment Response in Major Depression: A Replication Study. The International Journal of Neuropsychopharmacology. 24(3). 191–199. 32 indexed citations

14.

Schwarte, Kathrin, Manuela Cerina, Alexander M. Herrmann, et al.. (2017). Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease. Brain Behavior and Immunity. 66. 382–393. 38 indexed citations

15.

Schwarte, Kathrin, Oliver Ambrée, Christian Bürger, et al.. (2017). Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders. Journal of Neuroimmune Pharmacology. 13(1). 90–99. 48 indexed citations

16.

Domschke, Katharina, Nicola Tidow, Kathrin Schwarte, et al.. (2014). Serotonin transporter gene hypomethylation predicts impaired antidepressant treatment response. The International Journal of Neuropsychopharmacology. 17(8). 1167–1176. 114 indexed citations

17.

Domschke, Katharina, Nicola Tidow, Kathrin Schwarte, et al.. (2014). Pharmacoepigenetics of depression: no major influence of MAO-A DNA methylation on treatment response. Journal of Neural Transmission. 122(1). 99–108. 42 indexed citations

18.

Domschke, Katharina, Nicola Tidow, Kathrin Schwarte, et al.. (2013). Epigenetic signature of panic disorder: A role of glutamate decarboxylase 1 (GAD1) DNA hypomethylation?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 46. 189–196. 52 indexed citations

19.

Domschke, Katharina, Nicola Tidow, Kathrin Schwarte, et al.. (2012). Monoamine oxidase A gene DNA hypomethylation – a risk factor for panic disorder?. The International Journal of Neuropsychopharmacology. 15(9). 1217–1228. 81 indexed citations

20.

Hohoff, Christa, Katharina Domschke, Kathrin Schwarte, et al.. (2008). Sympathetic activity relates to adenosine A2A receptor gene variation in blood-injury phobia. Journal of Neural Transmission. 116(6). 659–662. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact